Click for best price
Nanopharmaceuticals Market Size, Share 2023
| Market size in 2022 |
US$ 31860 million
|
Forecast Market size by 2029 |
US$ 72390 million
|
| Growth Rate |
CAGR of 12.4% |
Number of Pages |
122 Pages |
Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their ?bulk? counterparts primarily because of size.
There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier.
This report aims to provide a comprehensive presentation of the global market for Nanopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanopharmaceuticals. This report contains market size and forecasts of Nanopharmaceuticals in global, including the following market information:
Global Nanopharmaceuticals Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Nanopharmaceuticals Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Nanopharmaceuticals companies in 2022 (%)
The global Nanopharmaceuticals market was valued at US$ 31860 million in 2022 and is projected to reach US$ 72390 million by 2029, at a CAGR of 12.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
USA is the largest Nanopharmaceuticals market with about 59% market share. Europe is follower, accounting for about 33% market share.
The key players are Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Roche, Sanofi, Eli Lilly, Astrazeneca, Johnson & Johnson, Celgene, Novavax, Stryker, Gilead Sciences, OSI Pharmaceuticals, Kadmon Pharmaceuticals, Samyang Biopharm, Mitsubishi Pharma, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Cerulean Pharma, Navidea Biopharmaceuticals, Lummy etc. Top 3 companies occupied about 34% market share.
We surveyed the Nanopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nanopharmaceuticals Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Nanopharmaceuticals Market Segment Percentages, by Type, 2022 (%)
Liposomes
Polymeric Micelles
Solid Lipid Nanoparticles
Microemulsion and Nnanoemulsion
Nanosuspension
Global Nanopharmaceuticals Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Nanopharmaceuticals Market Segment Percentages, by Application, 2022 (%)
Cancer and Tumor
Autoimmune Disorders
Inflammation
Others
Global Nanopharmaceuticals Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Nanopharmaceuticals Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nanopharmaceuticals revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Nanopharmaceuticals revenues share in global market, 2022 (%)
Key companies Nanopharmaceuticals sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Nanopharmaceuticals sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nanopharmaceuticals, market overview.
Chapter 2: Global Nanopharmaceuticals market size in revenue and volume.
Chapter 3: Detailed analysis of Nanopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nanopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Nanopharmaceuticals capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Nanopharmaceuticals Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 31860 million
|
| Forecast Market size by 2029 |
US$ 72390 million
|
| Growth Rate |
CAGR of 12.4% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
122 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nanopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nanopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nanopharmaceuticals Overall Market Size
2.1 Global Nanopharmaceuticals Market Size: 2022 VS 2029
2.2 Global Nanopharmaceuticals Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Nanopharmaceuticals Sales: 2018-2029
3 Company Landscape
3.1 Top Nanopharmaceuticals Players in Global Market
3.2 Top Global Nanopharmaceuticals Companies Ranked by Revenue
3.3 Global Nanopharmaceuticals Revenue by Companies
3.4 Global Nanopharmaceuticals Sales by Companies
3.5 Global Nanopharmaceuticals Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Nanopharmaceuticals Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Nanopharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nanopharmaceuticals Players in Global Market
3.8.1 List of Global Tier 1 Nanopharmaceuticals Companies
3.8.2 List of Global Tier 2 and Tier 3 Nanopharmaceuticals Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Nanopharmaceuticals Market Size Markets, 2022 & 2029
4.1.2 Liposomes
4.1.3 Polymeric Micelles
4.1.4 Solid Lipid Nanoparticles
4.1.5 Microemulsion and Nnanoemulsion
4.1.6 Nanosuspension
4.2 By Type - Global Nanopharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global Nanopharmaceuticals Revenue, 2018-2023
4.2.2 By Type - Global Nanopharmaceuticals Revenue, 2024-2029
4.2.3 By Type - Global Nanopharmaceuticals Revenue Market Share, 2018-2029
4.3 By Type - Global Nanopharmaceuticals Sales & Forecasts
4.3.1 By Type - Global Nanopharmaceuticals Sales, 2018-2023
4.3.2 By Type - Global Nanopharmaceuticals Sales, 2024-2029
4.3.3 By Type - Global Nanopharmaceuticals Sales Market Share, 2018-2029
4.4 By Type - Global Nanopharmaceuticals Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nanopharmaceuticals Market Size, 2022 & 2029
5.1.2 Cancer and Tumor
5.1.3 Autoimmune Disorders
5.1.4 Inflammation
5.1.5 Others
5.2 By Application - Global Nanopharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global Nanopharmaceuticals Revenue, 2018-2023
5.2.2 By Application - Global Nanopharmaceuticals Revenue, 2024-2029
5.2.3 By Application - Global Nanopharmaceuticals Revenue Market Share, 2018-2029
5.3 By Application - Global Nanopharmaceuticals Sales & Forecasts
5.3.1 By Application - Global Nanopharmaceuticals Sales, 2018-2023
5.3.2 By Application - Global Nanopharmaceuticals Sales, 2024-2029
5.3.3 By Application - Global Nanopharmaceuticals Sales Market Share, 2018-2029
5.4 By Application - Global Nanopharmaceuticals Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Nanopharmaceuticals Market Size, 2022 & 2029
6.2 By Region - Global Nanopharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global Nanopharmaceuticals Revenue, 2018-2023
6.2.2 By Region - Global Nanopharmaceuticals Revenue, 2024-2029
6.2.3 By Region - Global Nanopharmaceuticals Revenue Market Share, 2018-2029
6.3 By Region - Global Nanopharmaceuticals Sales & Forecasts
6.3.1 By Region - Global Nanopharmaceuticals Sales, 2018-2023
6.3.2 By Region - Global Nanopharmaceuticals Sales, 2024-2029
6.3.3 By Region - Global Nanopharmaceuticals Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Nanopharmaceuticals Revenue, 2018-2029
6.4.2 By Country - North America Nanopharmaceuticals Sales, 2018-2029
6.4.3 US Nanopharmaceuticals Market Size, 2018-2029
6.4.4 Canada Nanopharmaceuticals Market Size, 2018-2029
6.4.5 Mexico Nanopharmaceuticals Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Nanopharmaceuticals Revenue, 2018-2029
6.5.2 By Country - Europe Nanopharmaceuticals Sales, 2018-2029
6.5.3 Germany Nanopharmaceuticals Market Size, 2018-2029
6.5.4 France Nanopharmaceuticals Market Size, 2018-2029
6.5.5 U.K. Nanopharmaceuticals Market Size, 2018-2029
6.5.6 Italy Nanopharmaceuticals Market Size, 2018-2029
6.5.7 Russia Nanopharmaceuticals Market Size, 2018-2029
6.5.8 Nordic Countries Nanopharmaceuticals Market Size, 2018-2029
6.5.9 Benelux Nanopharmaceuticals Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Nanopharmaceuticals Revenue, 2018-2029
6.6.2 By Region - Asia Nanopharmaceuticals Sales, 2018-2029
6.6.3 China Nanopharmaceuticals Market Size, 2018-2029
6.6.4 Japan Nanopharmaceuticals Market Size, 2018-2029
6.6.5 South Korea Nanopharmaceuticals Market Size, 2018-2029
6.6.6 Southeast Asia Nanopharmaceuticals Market Size, 2018-2029
6.6.7 India Nanopharmaceuticals Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Nanopharmaceuticals Revenue, 2018-2029
6.7.2 By Country - South America Nanopharmaceuticals Sales, 2018-2029
6.7.3 Brazil Nanopharmaceuticals Market Size, 2018-2029
6.7.4 Argentina Nanopharmaceuticals Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Nanopharmaceuticals Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Nanopharmaceuticals Sales, 2018-2029
6.8.3 Turkey Nanopharmaceuticals Market Size, 2018-2029
6.8.4 Israel Nanopharmaceuticals Market Size, 2018-2029
6.8.5 Saudi Arabia Nanopharmaceuticals Market Size, 2018-2029
6.8.6 UAE Nanopharmaceuticals Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Nanopharmaceuticals Major Product Offerings
7.1.4 Merck Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Nanopharmaceuticals Major Product Offerings
7.2.4 Pfizer Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Nanopharmaceuticals Major Product Offerings
7.3.4 Novartis Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Abbott
7.4.1 Abbott Company Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Nanopharmaceuticals Major Product Offerings
7.4.4 Abbott Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.4.5 Abbott Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Nanopharmaceuticals Major Product Offerings
7.5.4 GlaxoSmithKline Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche Nanopharmaceuticals Major Product Offerings
7.6.4 Roche Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.6.5 Roche Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Nanopharmaceuticals Major Product Offerings
7.7.4 Sanofi Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 Eli Lilly
7.8.1 Eli Lilly Company Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Nanopharmaceuticals Major Product Offerings
7.8.4 Eli Lilly Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.8.5 Eli Lilly Key News & Latest Developments
7.9 Astrazeneca
7.9.1 Astrazeneca Company Summary
7.9.2 Astrazeneca Business Overview
7.9.3 Astrazeneca Nanopharmaceuticals Major Product Offerings
7.9.4 Astrazeneca Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.9.5 Astrazeneca Key News & Latest Developments
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Nanopharmaceuticals Major Product Offerings
7.10.4 Johnson & Johnson Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.10.5 Johnson & Johnson Key News & Latest Developments
7.11 Celgene
7.11.1 Celgene Company Summary
7.11.2 Celgene Nanopharmaceuticals Business Overview
7.11.3 Celgene Nanopharmaceuticals Major Product Offerings
7.11.4 Celgene Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.11.5 Celgene Key News & Latest Developments
7.12 Novavax
7.12.1 Novavax Company Summary
7.12.2 Novavax Nanopharmaceuticals Business Overview
7.12.3 Novavax Nanopharmaceuticals Major Product Offerings
7.12.4 Novavax Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.12.5 Novavax Key News & Latest Developments
7.13 Stryker
7.13.1 Stryker Company Summary
7.13.2 Stryker Nanopharmaceuticals Business Overview
7.13.3 Stryker Nanopharmaceuticals Major Product Offerings
7.13.4 Stryker Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.13.5 Stryker Key News & Latest Developments
7.14 Gilead Sciences
7.14.1 Gilead Sciences Company Summary
7.14.2 Gilead Sciences Business Overview
7.14.3 Gilead Sciences Nanopharmaceuticals Major Product Offerings
7.14.4 Gilead Sciences Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.14.5 Gilead Sciences Key News & Latest Developments
7.15 OSI Pharmaceuticals
7.15.1 OSI Pharmaceuticals Company Summary
7.15.2 OSI Pharmaceuticals Business Overview
7.15.3 OSI Pharmaceuticals Nanopharmaceuticals Major Product Offerings
7.15.4 OSI Pharmaceuticals Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.15.5 OSI Pharmaceuticals Key News & Latest Developments
7.16 Kadmon Pharmaceuticals
7.16.1 Kadmon Pharmaceuticals Company Summary
7.16.2 Kadmon Pharmaceuticals Business Overview
7.16.3 Kadmon Pharmaceuticals Nanopharmaceuticals Major Product Offerings
7.16.4 Kadmon Pharmaceuticals Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.16.5 Kadmon Pharmaceuticals Key News & Latest Developments
7.17 Samyang Biopharm
7.17.1 Samyang Biopharm Company Summary
7.17.2 Samyang Biopharm Business Overview
7.17.3 Samyang Biopharm Nanopharmaceuticals Major Product Offerings
7.17.4 Samyang Biopharm Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.17.5 Samyang Biopharm Key News & Latest Developments
7.18 Mitsubishi Pharma
7.18.1 Mitsubishi Pharma Company Summary
7.18.2 Mitsubishi Pharma Business Overview
7.18.3 Mitsubishi Pharma Nanopharmaceuticals Major Product Offerings
7.18.4 Mitsubishi Pharma Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.18.5 Mitsubishi Pharma Key News & Latest Developments
7.19 Kaken Pharmaceutical
7.19.1 Kaken Pharmaceutical Company Summary
7.19.2 Kaken Pharmaceutical Business Overview
7.19.3 Kaken Pharmaceutical Nanopharmaceuticals Major Product Offerings
7.19.4 Kaken Pharmaceutical Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.19.5 Kaken Pharmaceutical Key News & Latest Developments
7.20 Selecta Biosciences
7.20.1 Selecta Biosciences Company Summary
7.20.2 Selecta Biosciences Business Overview
7.20.3 Selecta Biosciences Nanopharmaceuticals Major Product Offerings
7.20.4 Selecta Biosciences Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.20.5 Selecta Biosciences Key News & Latest Developments
7.21 Par Pharmaceutical
7.21.1 Par Pharmaceutical Company Summary
7.21.2 Par Pharmaceutical Business Overview
7.21.3 Par Pharmaceutical Nanopharmaceuticals Major Product Offerings
7.21.4 Par Pharmaceutical Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.21.5 Par Pharmaceutical Key News & Latest Developments
7.22 Cerulean Pharma
7.22.1 Cerulean Pharma Company Summary
7.22.2 Cerulean Pharma Business Overview
7.22.3 Cerulean Pharma Nanopharmaceuticals Major Product Offerings
7.22.4 Cerulean Pharma Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.22.5 Cerulean Pharma Key News & Latest Developments
7.23 Navidea Biopharmaceuticals
7.23.1 Navidea Biopharmaceuticals Company Summary
7.23.2 Navidea Biopharmaceuticals Business Overview
7.23.3 Navidea Biopharmaceuticals Nanopharmaceuticals Major Product Offerings
7.23.4 Navidea Biopharmaceuticals Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.23.5 Navidea Biopharmaceuticals Key News & Latest Developments
7.24 Lummy
7.24.1 Lummy Company Summary
7.24.2 Lummy Business Overview
7.24.3 Lummy Nanopharmaceuticals Major Product Offerings
7.24.4 Lummy Nanopharmaceuticals Sales and Revenue in Global (2018-2023)
7.24.5 Lummy Key News & Latest Developments
8 Global Nanopharmaceuticals Production Capacity, Analysis
8.1 Global Nanopharmaceuticals Production Capacity, 2018-2029
8.2 Nanopharmaceuticals Production Capacity of Key Manufacturers in Global Market
8.3 Global Nanopharmaceuticals Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Nanopharmaceuticals Supply Chain Analysis
10.1 Nanopharmaceuticals Industry Value Chain
10.2 Nanopharmaceuticals Upstream Market
10.3 Nanopharmaceuticals Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nanopharmaceuticals Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Nanopharmaceuticals in Global Market
Table 2. Top Nanopharmaceuticals Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Nanopharmaceuticals Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Nanopharmaceuticals Revenue Share by Companies, 2018-2023
Table 5. Global Nanopharmaceuticals Sales by Companies, (K MT), 2018-2023
Table 6. Global Nanopharmaceuticals Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Nanopharmaceuticals Price (2018-2023) & (USD/MT)
Table 8. Global Manufacturers Nanopharmaceuticals Product Type
Table 9. List of Global Tier 1 Nanopharmaceuticals Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nanopharmaceuticals Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Nanopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Nanopharmaceuticals Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Nanopharmaceuticals Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Nanopharmaceuticals Sales (K MT), 2018-2023
Table 15. By Type - Global Nanopharmaceuticals Sales (K MT), 2024-2029
Table 16. By Application ? Global Nanopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Nanopharmaceuticals Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Nanopharmaceuticals Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Nanopharmaceuticals Sales (K MT), 2018-2023
Table 20. By Application - Global Nanopharmaceuticals Sales (K MT), 2024-2029
Table 21. By Region ? Global Nanopharmaceuticals Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Nanopharmaceuticals Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Nanopharmaceuticals Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Nanopharmaceuticals Sales (K MT), 2018-2023
Table 25. By Region - Global Nanopharmaceuticals Sales (K MT), 2024-2029
Table 26. By Country - North America Nanopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Nanopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Nanopharmaceuticals Sales, (K MT), 2018-2023
Table 29. By Country - North America Nanopharmaceuticals Sales, (K MT), 2024-2029
Table 30. By Country - Europe Nanopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Nanopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Nanopharmaceuticals Sales, (K MT), 2018-2023
Table 33. By Country - Europe Nanopharmaceuticals Sales, (K MT), 2024-2029
Table 34. By Region - Asia Nanopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Nanopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Nanopharmaceuticals Sales, (K MT), 2018-2023
Table 37. By Region - Asia Nanopharmaceuticals Sales, (K MT), 2024-2029
Table 38. By Country - South America Nanopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Nanopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Nanopharmaceuticals Sales, (K MT), 2018-2023
Table 41. By Country - South America Nanopharmaceuticals Sales, (K MT), 2024-2029
Table 42. By Country - Middle East & Africa Nanopharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Nanopharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Nanopharmaceuticals Sales, (K MT), 2018-2023
Table 45. By Country - Middle East & Africa Nanopharmaceuticals Sales, (K MT), 2024-2029
Table 46. Merck Company Summary
Table 47. Merck Nanopharmaceuticals Product Offerings
Table 48. Merck Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Nanopharmaceuticals Product Offerings
Table 52. Pfizer Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Nanopharmaceuticals Product Offerings
Table 56. Novartis Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. Abbott Company Summary
Table 59. Abbott Nanopharmaceuticals Product Offerings
Table 60. Abbott Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 61. Abbott Key News & Latest Developments
Table 62. GlaxoSmithKline Company Summary
Table 63. GlaxoSmithKline Nanopharmaceuticals Product Offerings
Table 64. GlaxoSmithKline Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 65. GlaxoSmithKline Key News & Latest Developments
Table 66. Roche Company Summary
Table 67. Roche Nanopharmaceuticals Product Offerings
Table 68. Roche Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 69. Roche Key News & Latest Developments
Table 70. Sanofi Company Summary
Table 71. Sanofi Nanopharmaceuticals Product Offerings
Table 72. Sanofi Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 73. Sanofi Key News & Latest Developments
Table 74. Eli Lilly Company Summary
Table 75. Eli Lilly Nanopharmaceuticals Product Offerings
Table 76. Eli Lilly Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 77. Eli Lilly Key News & Latest Developments
Table 78. Astrazeneca Company Summary
Table 79. Astrazeneca Nanopharmaceuticals Product Offerings
Table 80. Astrazeneca Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 81. Astrazeneca Key News & Latest Developments
Table 82. Johnson & Johnson Company Summary
Table 83. Johnson & Johnson Nanopharmaceuticals Product Offerings
Table 84. Johnson & Johnson Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 85. Johnson & Johnson Key News & Latest Developments
Table 86. Celgene Company Summary
Table 87. Celgene Nanopharmaceuticals Product Offerings
Table 88. Celgene Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 89. Celgene Key News & Latest Developments
Table 90. Novavax Company Summary
Table 91. Novavax Nanopharmaceuticals Product Offerings
Table 92. Novavax Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 93. Novavax Key News & Latest Developments
Table 94. Stryker Company Summary
Table 95. Stryker Nanopharmaceuticals Product Offerings
Table 96. Stryker Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 97. Stryker Key News & Latest Developments
Table 98. Gilead Sciences Company Summary
Table 99. Gilead Sciences Nanopharmaceuticals Product Offerings
Table 100. Gilead Sciences Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 101. Gilead Sciences Key News & Latest Developments
Table 102. OSI Pharmaceuticals Company Summary
Table 103. OSI Pharmaceuticals Nanopharmaceuticals Product Offerings
Table 104. OSI Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 105. OSI Pharmaceuticals Key News & Latest Developments
Table 106. Kadmon Pharmaceuticals Company Summary
Table 107. Kadmon Pharmaceuticals Nanopharmaceuticals Product Offerings
Table 108. Kadmon Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 109. Kadmon Pharmaceuticals Key News & Latest Developments
Table 110. Samyang Biopharm Company Summary
Table 111. Samyang Biopharm Nanopharmaceuticals Product Offerings
Table 112. Samyang Biopharm Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 113. Samyang Biopharm Key News & Latest Developments
Table 114. Mitsubishi Pharma Company Summary
Table 115. Mitsubishi Pharma Nanopharmaceuticals Product Offerings
Table 116. Mitsubishi Pharma Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 117. Mitsubishi Pharma Key News & Latest Developments
Table 118. Kaken Pharmaceutical Company Summary
Table 119. Kaken Pharmaceutical Nanopharmaceuticals Product Offerings
Table 120. Kaken Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 121. Kaken Pharmaceutical Key News & Latest Developments
Table 122. Selecta Biosciences Company Summary
Table 123. Selecta Biosciences Nanopharmaceuticals Product Offerings
Table 124. Selecta Biosciences Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 125. Selecta Biosciences Key News & Latest Developments
Table 126. Par Pharmaceutical Company Summary
Table 127. Par Pharmaceutical Nanopharmaceuticals Product Offerings
Table 128. Par Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 129. Par Pharmaceutical Key News & Latest Developments
Table 130. Cerulean Pharma Company Summary
Table 131. Cerulean Pharma Nanopharmaceuticals Product Offerings
Table 132. Cerulean Pharma Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 133. Cerulean Pharma Key News & Latest Developments
Table 134. Navidea Biopharmaceuticals Company Summary
Table 135. Navidea Biopharmaceuticals Nanopharmaceuticals Product Offerings
Table 136. Navidea Biopharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 137. Navidea Biopharmaceuticals Key News & Latest Developments
Table 138. Lummy Company Summary
Table 139. Lummy Nanopharmaceuticals Product Offerings
Table 140. Lummy Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 141. Lummy Key News & Latest Developments
Table 142. Nanopharmaceuticals Production Capacity (K MT) of Key Manufacturers in Global Market, 2021-2023 (K MT)
Table 143. Global Nanopharmaceuticals Capacity Market Share of Key Manufacturers, 2021-2023
Table 144. Global Nanopharmaceuticals Production by Region, 2018-2023 (K MT)
Table 145. Global Nanopharmaceuticals Production by Region, 2024-2029 (K MT)
Table 146. Nanopharmaceuticals Market Opportunities & Trends in Global Market
Table 147. Nanopharmaceuticals Market Drivers in Global Market
Table 148. Nanopharmaceuticals Market Restraints in Global Market
Table 149. Nanopharmaceuticals Raw Materials
Table 150. Nanopharmaceuticals Raw Materials Suppliers in Global Market
Table 151. Typical Nanopharmaceuticals Downstream
Table 152. Nanopharmaceuticals Downstream Clients in Global Market
Table 153. Nanopharmaceuticals Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Nanopharmaceuticals Segment by Type in 2022
Figure 2. Nanopharmaceuticals Segment by Application in 2022
Figure 3. Global Nanopharmaceuticals Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nanopharmaceuticals Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Nanopharmaceuticals Revenue, 2018-2029 (US$, Mn)
Figure 7. Nanopharmaceuticals Sales in Global Market: 2018-2029 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Nanopharmaceuticals Revenue in 2022
Figure 9. By Type - Global Nanopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Nanopharmaceuticals Revenue Market Share, 2018-2029
Figure 11. By Type - Global Nanopharmaceuticals Sales Market Share, 2018-2029
Figure 12. By Type - Global Nanopharmaceuticals Price (USD/MT), 2018-2029
Figure 13. By Application - Global Nanopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Nanopharmaceuticals Revenue Market Share, 2018-2029
Figure 15. By Application - Global Nanopharmaceuticals Sales Market Share, 2018-2029
Figure 16. By Application - Global Nanopharmaceuticals Price (USD/MT), 2018-2029
Figure 17. By Region - Global Nanopharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Nanopharmaceuticals Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Nanopharmaceuticals Revenue Market Share, 2018-2029
Figure 20. By Region - Global Nanopharmaceuticals Sales Market Share, 2018-2029
Figure 21. By Country - North America Nanopharmaceuticals Revenue Market Share, 2018-2029
Figure 22. By Country - North America Nanopharmaceuticals Sales Market Share, 2018-2029
Figure 23. US Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Nanopharmaceuticals Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Nanopharmaceuticals Sales Market Share, 2018-2029
Figure 28. Germany Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 29. France Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Nanopharmaceuticals Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Nanopharmaceuticals Sales Market Share, 2018-2029
Figure 37. China Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 41. India Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Nanopharmaceuticals Revenue Market Share, 2018-2029
Figure 43. By Country - South America Nanopharmaceuticals Sales Market Share, 2018-2029
Figure 44. Brazil Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Nanopharmaceuticals Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Nanopharmaceuticals Sales Market Share, 2018-2029
Figure 48. Turkey Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Nanopharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 52. Global Nanopharmaceuticals Production Capacity (K MT), 2018-2029
Figure 53. The Percentage of Production Nanopharmaceuticals by Region, 2022 VS 2029
Figure 54. Nanopharmaceuticals Industry Value Chain
Figure 55. Marketing Channels
